PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
5.73%
Revenue growth below 50% of VET's 31.36%. Michael Burry would check for competitive disadvantage risks.
1.43%
Cost growth less than half of VET's 14.40%. David Dodd would verify if cost advantage is structural.
14.09%
Gross profit growth below 50% of VET's 48.69%. Michael Burry would check for structural issues.
7.90%
Margin expansion 50-75% of VET's 13.20%. Martin Whitman would scrutinize competitive position.
No Data
No Data available this quarter, please select a different quarter.
-6.01%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
No Data
No Data available this quarter, please select a different quarter.
-14.29%
Other expenses reduction while VET shows 39.29% growth. Joel Greenblatt would examine efficiency.
-3.13%
Operating expenses reduction while VET shows 0.38% growth. Joel Greenblatt would examine advantage.
-0.28%
Total costs reduction while VET shows 8.64% growth. Joel Greenblatt would examine advantage.
-22.22%
Both companies reducing interest expense. Martin Whitman would check industry trends.
-4.73%
D&A reduction while VET shows 11.52% growth. Joel Greenblatt would examine efficiency.
45.97%
EBITDA growth while VET declines. John Neff would investigate advantages.
31.64%
EBITDA margin growth exceeding 1.5x VET's 20.19%. David Dodd would verify competitive advantages.
104.96%
Operating income growth 50-75% of VET's 169.65%. Martin Whitman would scrutinize operations.
104.69%
Similar operating margin growth to VET's 105.28%. Walter Schloss would investigate industry trends.
8.33%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
65.37%
Pre-tax income growth while VET declines. John Neff would investigate advantages.
67.24%
Pre-tax margin growth while VET declines. John Neff would investigate advantages.
-99.06%
Both companies reducing tax expense. Martin Whitman would check patterns.
64.88%
Net income growth while VET declines. John Neff would investigate advantages.
66.78%
Net margin growth while VET declines. John Neff would investigate advantages.
64.56%
EPS growth while VET declines. John Neff would investigate advantages.
64.56%
Diluted EPS growth while VET declines. John Neff would investigate advantages.
-0.91%
Share count reduction while VET shows 0.08% change. Joel Greenblatt would examine strategy.
No Data
No Data available this quarter, please select a different quarter.